Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)

BACKGROUND: Despite the survival advantage, not all metastatic renal cell carcinoma (mRCC) patients achieve a long-term benefit from immunotherapy. Moreover, the identification of prognostic biomarkers is still an unmet clinical need. METHODS: This multicenter retrospective study investigated the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebuzzi, Sara Elena, Signori, Alessio, Banna, Giuseppe Luigi, Maruzzo, Marco, De Giorgi, Ugo, Pedrazzoli, Paolo, Sbrana, Andrea, Zucali, Paolo Andrea, Masini, Cristina, Naglieri, Emanuele, Procopio, Giuseppe, Merler, Sara, Tomasello, Laura, Fratino, Lucia, Baldessari, Cinzia, Ricotta, Riccardo, Panni, Stefano, Mollica, Veronica, Sorarù, Maria, Santoni, Matteo, Cortellini, Alessio, Prati, Veronica, Soto Parra, Hector Josè, Stellato, Marco, Atzori, Francesco, Pignata, Sandro, Messina, Carlo, Messina, Marco, Morelli, Franco, Prati, Giuseppe, Nolè, Franco, Vignani, Francesca, Cavo, Alessia, Roviello, Giandomenico, Pierantoni, Francesco, Casadei, Chiara, Bersanelli, Melissa, Chiellino, Silvia, Paolieri, Federico, Perrino, Matteo, Brunelli, Matteo, Iacovelli, Roberto, Porta, Camillo, Buti, Sebastiano, Fornarini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135208/
https://www.ncbi.nlm.nih.gov/pubmed/34046089
http://dx.doi.org/10.1177/17588359211019642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135208/
https://www.ncbi.nlm.nih.gov/pubmed/34046089
http://dx.doi.org/10.1177/17588359211019642

Ejemplares similares